• 42 Hits
  • Search Condition : Filter (MeSH = Immunotherapy)
Species Resource Title
DNA material CSII-EF-MCS-IRES2-Venus (RDB04384) , CS-RfA-EG (RDB04391) , pCAG-HIVgp (RDB04394) , pCMV-VSV-G-RSV-Rev (RDB04393) T Cell-Intrinsic Vitamin A Metabolism and Its Signaling Are Targets for Memory T Cell-Based Cancer Immunotherapy.
Human and Animal Cells Colon-26(RCB2657) Combining an Alarmin HMGN1 Peptide with PD-L1 Blockade Results in Robust Antitumor Effects with a Concomitant Increase of Stem-Like/Progenitor Exhausted CD8+ T Cells.
Human and Animal Cells OP9/N-DLL1(RCB2927) Generation of induced pluripotent stem cell (iPSC) from NY-ESO-I-specific cytotoxic T cells isolated from the melanoma patient with minor HLAs: The practical pilot study for the adoptive immunotherapy for melanoma using iPSC technology.
Human and Animal Cells RAW 264(RCB0535) The VIPR2-selective antagonist KS-133 changes macrophage polarization and exerts potent anti-tumor effects as a single agent and in combination with an anti-PD-1 antibody.
Human and Animal Cells B16/BL6(RCB2638) Development of allergic rhinitis immunotherapy using antigen-loaded small extracellular vesicles.
Human and Animal Cells , DNA material 293T(RCB2202) , LLC(RCB0568) , Colon-26(RCB2657) , CSII-CMV-MCS (RDB04377) , pCMV-VSV-G-RSV-Rev (RDB04393) , pCAG-HIVgp (RDB04394) Angiogenic inhibitor pre-administration improves the therapeutic effects of immunotherapy.
Human and Animal Cells B16 Induction of antigen-specific immune responses against malignant brain tumors by intramuscular injection of sindbis DNA encoding gp100 and IL-18.
Human and Animal Cells BALL-1(RCB0256) PD-1+ Tim3+ tumor-infiltrating CD8 T cells sustain the potential for IFN-γ production, but lose cytotoxic activity in ovarian cancer.
Human and Animal Cells HuH-7 Development of T cells redirected to glypican-3 for the treatment of hepatocellular carcinoma.
Human and Animal Cells THP-1 Tumor microenvironment regulation - enhanced radio - immunotherapy.
Human and Animal Cells YAC-1(RCB1165) Antitumor effect of immunizations with fusions of dendritic and glioma cells in a mouse brain tumor model.
Human and Animal Cells RAW 264(RCB0535) Anti-tumor immunity by transcriptional synergy between TLR9 and STING activation.
Human and Animal Cells HSC-2(RCB1945) , HSC-3(RCB1975) , HSC-4(RCB1902) , Sa3(RCB0980) Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma.
Human and Animal Cells EBC-1(RCB1965) , A549 , HSC-4(RCB1902) , LU65(RCB1967) A stealth antigen SPESP1, which is epigenetically silenced in tumors, is a suitable target for cancer immunotherapy.
Human and Animal Cells RAW 264(RCB0535) , B16F10(RCB2630) , 293T(RCB2202) Orchestration of myeloid-derived suppressor cells in the tumor microenvironment by ubiquitous cellular protein TCTP released by tumor cells.
Human and Animal Cells iPS-MEF-Ng-20D-17(APS0001) Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice.
Human and Animal Cells PC-9(RCB4455) Synthesis and Immunomodulatory Activity of Fluorine-Containing Bisphosphonates.
Human and Animal Cells NIH3T3 Systemic DC Activation Modulates the Tumor Microenvironment and Shapes the Long-Lived Tumor-Specific Memory Mediated by CD8+ T Cells.
Human and Animal Cells Jurkat Establishment of a stable T lymphoma cell line transduced with HLA-A*24:02-restricted WT1-specific TCR genes and its application to antigen-specific immunomonitoring.
Human and Animal Cells U251(RCB0461) Functional analysis of KIF20A, a potential immunotherapeutic target for glioma.